Follistatin

Follistatin is an endogenous protein that binds and neutralizes myostatin and activin A — both negative regulators of muscle growth. The two most-discussed research forms are Follistatin-344 and Follistatin-315, distinguished by their C-terminal length and tissue affinity. The shorter Follistatin-315 circulates more freely in serum, while Follistatin-344 binds more tightly to cell surfaces. Both are studied as potential muscle-growth and anti-fibrotic agents. They are sold strictly for laboratory research.

Your body has a built-in brake on muscle growth called myostatin. Follistatin is the body's own brake-release: it binds myostatin and removes it from circulation, allowing muscles to grow more freely. Famous cases of natural myostatin or follistatin variation — like the 'super-muscular' Belgian Blue cattle or rare humans with myostatin mutations — show how dramatic this pathway can be. Follistatin is one of the most-discussed compounds in muscle-growth research.

Follistatin binds myostatin and activin A with high affinity, preventing them from engaging their receptors (ActRIIB) on muscle cells. With the inhibitory signal blocked, downstream Smad2/3 signaling drops and the AKT/mTOR muscle-growth pathway is allowed to operate at higher capacity. Follistatin-344 has stronger heparan-sulfate binding and tends to act more locally; Follistatin-315 circulates more broadly.

• •Muscular dystrophy gene therapy (AAV-follistatin)
• •Inclusion body myositis trials
• •Sarcopenia and age-related muscle loss
• •Fibrosis research (anti-activin effects)
• •Comparative myostatin-pathway pharmacology

Follistatin is a perennial topic on bodybuilding and biohacking forums, often alongside ACE-031 and YK-11 in 'myostatin inhibitor' discussions. Most online debate concerns whether grey-market 'Follistatin-344' is real, properly folded protein — synthesizing a 344-residue protein with correct disulfide structure is far more difficult than producing a small peptide. Reports vary wildly, and quality is a major concern.

“The body's own muscle-brake release.”

Follistatin is sometimes paired with ACE-031 in theoretical myostatin-pathway stacks, with GH-secretagogue protocols (CJC-1295 + ipamorelin) for independent pathway combination, or with BPC-157 in recovery contexts. None of these are clinically validated combinations.

Follistatin is an endogenous myostatin- and activin-binding protein studied for muscle growth, anti-fibrotic effects, and muscular dystrophy gene therapy. Research-grade Follistatin-344 and -315 are sold for laboratory use only, with significant concerns about quality and folding in the grey market.